We report an evaluation of the Bard Harvard Mini Infuser, one of a new generation of agent-specific intraoperative infusion pumps which are designed for use by the anaesthetist. This pump permits potent intravenous anaesthetic agents to be used in pharmacokinetically designed dosage regimens. The controls are calibrated directly in kg body weight and micrograms per minute rather than the usual settings of ml of solution per hour. The performance was assessed by measuring the volume delivered over given time intervals and all safety functions were tested at least three times. This device was found to be acceptably safe and accurate. Two points to note are that it must be purged every time before it is connected to the intravenous infusion and if an occlusion is suddenly relieved, the patient can receive an 'accidental bolus' of up to 1.18 ml of drug.
Modern intravenous anaesthetic agents are potent and rapid-acting; many are rapidly eliminated and non-cumulative and their introduction has been reported to give greater control of anaesthesia. 1 Most are administered by bolus doses, but increasing knowledge of population pharmacokinetics means that dosage regimens can be designed to rapidly attain and reliably maintain therapeutic plasma concentrations, maximising the therapeutic qualities of the drug and minimising its adverse effects.2 Just as there was a need for improved delivery systems for volatile agents when halothane was introduced, there is now a need for improved infusion devices capable of administering intravenous anaesthetic agents in dosage schemes dictated by their pharmacokinetic profiles, thus maintaining the plasma concentration of the drug steady and within the therapeutic range. 3 The ideal infusion device for these anaesthetic agents should be able to accurately deliver a loading dose, calculated from the initial volume of distribution, followed by a constant-rate infusion, to replace the drug which has been eliminated and at the same time deliver an exponentially declining infusion at a rate to compensate for the transfer of drug from the 'central' compartment to the 'peripheral' compartment(s). Such devices exist 4 but require the knowledge of the appropriate 'compartmental' data for the drug, the appropriate physical parameters of the patient and the computer, software and infusion pump. For routine clinical anaesthesia, a simpler infusion device is more appropriate, one which is able to deliver bolus doses rapidly and accurately and have a wide range of infusion rates which can be set according to clinical signs of anaesthesia. In order to minimise the arithmetical errors during drug dilution the device should have sufficient accuracy to deliver the drug undiluted (i.e. ampoule concentration) and be calibrated for the drug itself (e.g. in mg or mglkg). In addition, as with all modern anaesthetic equipment, it should have suitable alarms for patient safety.
Recently a new generation of infusion devices has been produced specifically designed for operating theatre use with most of all of the above characteristics. This report is the first to describe one such sophisticated device, the Bard Harvard Mini Infuser, and to evaluate its accuracy and reliability.
METHODS

Description of infuser
The 'Havard Mini Infuser' is an intravenous infusion pump which is designed specifically to be used with drugs whose concentration is 500 mcg/ml. It is battery operated and accepts either Monoject® or Becton Dickinson (BD) 60 ml syringes. Drug delivery is in a controlled manner by means of a threaded lead screw rotated by a miniature motor. The speed of the motor is controlled by a microprocessor which also controls the display and alarm systems. The front panel of the infuser has four rotary switches, a fivecharacter liquid crystal display (LCD) and three small lights which either confirm the pump is operational or alerts the operator that a problem has arisen.
The top three rotary switches enable the anaesthetist to enter the patient's weight, size of the bolus and rate of infusion. These are directly calibrated in kg, mcg/kg, and mcg/kg/min respectively, avoiding the need for any special calculations. The scales range from 30 to 100 kg, from 0 to 150 mcg/kg, and from 0 to 3.0 mcg/kg/ min, with twelve settings on each scale. The fourth rotary switch is a function switch which has separate settings to 'purge' the system, and for bolus injection, infusion and stop. 'Stop' allows the pump to be stopped temporarily without losing the information stored in the memory. The switch needs to be turned to off before the purge function can be reached. The LCD panel has a double function; during normal operation it displays the cumulative delivered dose, but in the event of an alarm it displays the cause of the problem. This event is accompanied by an audible alarm (buzzer) and a flashing red light which can only be cancelled by ceasing the infusion or correcting the fault.
The syringe is loaded into the pump with the barrel being held in a moulded clamp and the plunger of the syringe being attached to a moveable lever. The lever has an anti-siphon latch to prevent the syringe from emptying under the force of gravity alone. The manufacturer specifies use of Harvard Microbore High Flow delivery tubing.
Laboratory testing
Two pumps were evaluated under identical conditions. Both had undergone the manufacturer's normal control checks and had been supplied for use in the operating theatre. The accuracy and consistency of operation ofthe pumps was tested first. A BD syringe filled with normal saline was connected to the delivery tubing and installed in the pump. A 22 gauge IV cannula was attached to the tubing and directed into a measuring cylinder placed on an electronic balance (Mettler PL 1200, accurate to 0.01 mg). Before each test the system was purged in a uniform manner and the balance tared. A dose was selected and the infuser turned on. For infusions the weight of fluid delivered was recorded every ten seconds for the first ten minutes and then every three minutes for one hour. For bolus doses recordings were made every ten seconds until the full dose was delivered. The volume delivered was calculated from the weight of saline and its specific gravity at room temperature. Every second setting over the full range of the device was tested. Three settings, used most frequently in clinical use, were tested three times to evaluate consistency of operation. Accuracy of operation at extremes of syringe travel was also determined.
All of the following safety features were tested at least three times at different settings.
Line occlusion
The delivery tubing was occluded by a three-way stopcock. Line pressure developed by the infuser was measured by a Bourdon gauge calibrated against a column of mercury. The time taken until the occlusion alarm sounded and the pressure at that time were recorded. The volume which was released as a 'bolus' when the occlusion was relieved was measured. Similarly, operation of the device during partial occlusion of the infusion line (using a 27 gauge hypodermic needle attached to the delivery tubing) was examined.
Low battery
The accuracy of the pumps in delivering a bolus and an infusion using previously 'expired' batteries was measured as above.
Syringe empty
The volume of saline remaining in the syringe when this alarm sounded was measured.
RESULTS
Accuracy of mini infuser Constant infusion
In all cases both pumps under-infused slightly. The discrepancy between the delivered volume and the volumes which should have been delivered after one hour is shown for each setting tested (Table 1) . Most settings were well within 10% of expected values. (Some typical flow patterns are shown in Figure 1 .) However, failure to set the pump to 'purge' prior to testing caused a significant under infusion. This can result in an under-infusion, after one hour, of up to 32% when using the lowest infusion rate. The purge must be done using the machine's purge switch as the under-infusion appears to be due to 'take up' of a slight amount of mechanical slack in the system and to overcome the compliance of the tubing etc.
Bolus dose
The pumps deliver the 'bolus dose' as a very rapid infusion at a rate of 180 to 600 ml per hour equivalent to 1. 100 mcg/kg bolus was 124 seconds. The discrepancies between the volumes delivered and the expected volumes are shown in Table 2 . Figure 3 . The dose of 100 mcg/kg of alfentanil followed by 1.0 mcg/kg/min is often used in theatre and is recommended for anaesthesia for upper abdominal surgery. The error is a product of the error of the bolus dose and error of infusion rate.
Bolus and infusion A bolus and infusion flow pattern is shown in
Safety features
The results of the tests of the safety features are shown in Table 3 . The accuracy of the pump on 'low voltage' batteries was similar to that obtained 
DISCUSSION
The mini infuser proved to be reliable and consistent on laboratory testing. Two pumps were tested and both showed similar operational characteristics, and there were no systematic differences between the two devices. Both pumps have a slight tendency to under-infuse and at the least accurate settings, the pump under-infused by 12-15%. Taken over one hour at the least accurate setting, one of the pumps would have delivered 136 mcg less than the expected 1050 mcg, a discrepancy unlikely to have any clinical implications. In a recent review of syringe pump SS it was recommended that an accuracy of ± 5% should be taken as acceptable for infusion settings between 5
and 50 mlIhr and ± 10% for higher settings. This type of pump was not sufficiently accurate to meet this specification, but for alfentanil there are large variations in pharmacokinetic and pharmacodynamic parameters so the absolute accuracy of the infusion pump must be considered in this context. One point which is important but is not stressed in the manufacturer's manual is the importance of setting this type of infusion pump to 'purge' prior to commencing infusion. A situation could arise in the clinical setting when a syringe is changed during a prolonged anaesthetic without 'purging' the pump. The pump needs to be turned off before it can be purged. Obviously the pump must not be purged when connected to the patient. All the bolus doses were within ± 10% with the larger doses being considerably more accurate, and this is clinically acceptable. The bolus plus infusion study confirmed the results from the individual bolus and infusion tests. No accuracy was lost when a 27 gauge IV needle was added to the infusion line to produce back pressure. Also tests carried out when the syringe was deliberately filled to the maximum possible and the syringe was allowed to run until empty showed no change in accuracy.
The alarm features all worked consistently ( Table  3 ). The time taken for the occlusion alarm depends on reaching a set pressure level and therefore varied inversely with the infusion speed. With the infuser set at the rate most often used clinically, 1.0 mcg/ kg/min, for a 70 kg man, the time interval was 9 minutes and 40 seconds (Table 3) representing a failure to deliver 679 mcg of alfentanil. This time interval would appear to be unacceptibly long and although the pressure alarm falls within recommended guidelines, a more sensitive pressure alarm would be an improvement. It should be noted that with a line occlusion the pressure is maintained even though the alarm sounds and that relieving the pressure, e.g. opening a three-way tap, results in a 'bolus' of 1.18 ± 0.21 ml (equivalent to 590 mcg of alfentanil). As the batteries reach a low voltage a warning '10 batt' is displayed. This is useful and the batteries can be changed later, between cases or at the end of a theatre list since the pump still infuses accurately at this point. Eventually as the voltage drops further (below 4.5 V according to the manufacturer) the alarm sounds and the pump ceases infusion. The alarm reliably sounds just prior to the syringe completely emptying (residual volume 0.8 ml ± 0.03) but no earlier warning is given to the anaesthetist. A '10 voI' warning could be useful in such devices. Thus we have found that the pump is accurate to within 10% for most settings, but that the manufacturer's claims of within 3% apply only to the larger dose settings.
Since the device is for drugs at a concentration of 500 mcglml it is most useful for alfentanil and this is suggested on a panel on the pump. Labels can be designed which fix to the front panel and allow a range of drug concentrations to be used: these are also available commercially. They are not recommended by the manufacturer so that the device's specificity is its major drawback. Different companies are addressing this problem in different ways. One approach is to simply expand the range Anaesthesia and Intensive Care. Vo!. 18. No. 4. November. 1990 of infusion rates available from a simple syringe driver. The authors believe, for all the infuser's advantages described above, that this is unsatisfactory. Another approach is to design a pump that can be programed as to which drug is being infused and automatically adjust the drive train to suit. The development of these new devices suggests that intravenous drug infusion in theatre is about to undergo major change.
